首页 > 最新文献

Journal of Thyroid Research最新文献

英文 中文
Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma TNF-α与粘附分子l -选择素、VCAM-1在甲状腺乳头状癌中的意义
IF 2.1 Q2 Medicine Pub Date : 2016-01-11 DOI: 10.1155/2016/8143695
T. Kobawala, T. Trivedi, K. Gajjar, Darshita H. Patel, G. Patel, N. Ghosh
Circulating levels of TNF-α and the adhesion molecules L-Selectin and VCAM-1 as well as their expression in the primary tumors of patients with benign thyroid diseases and papillary thyroid carcinoma (PTC) have been determined in this study. The serum levels of TNF-α, L-Selectin, and VCAM-1 were significantly higher in patients with both benign thyroid diseases and PTC as compared to the healthy individuals. However, the levels of only TNF-α and L-Selectin, and not VCAM-1, were significantly higher in patients with PTC in comparison to those observed in patients with benign thyroid diseases. Further the expression of TNF-α and L-Selectin was also significantly higher in the primary tumors of PTC patients, relative to the benign thyroid diseases. The expression of L-Selectin and VCAM-1 significantly correlated with aggressive tumor behavior. In PTC patients, the circulating TNF-α levels significantly positively correlated with the levels of L-Selectin, while TNF-α immunoreactivity was significantly associated with VCAM-1 expression. Serum TNF-α was found to be a significant prognosticator for OS in PTC patients. Overall the results signify that the interaction between TNF-α and the adhesion molecules may have a role in thyroid carcinogenesis and understanding this complexity may offer potential therapeutic targets for better management of thyroid cancer.
本研究测定了良性甲状腺疾病和甲状腺乳头状癌(PTC)原发肿瘤中循环TNF-α、粘附分子l -选择素和VCAM-1的水平及其表达。良性甲状腺疾病和PTC患者血清TNF-α、l -选择素和VCAM-1水平均显著高于健康人。然而,与良性甲状腺疾病患者相比,PTC患者中只有TNF-α和l -选择素的水平明显升高,而VCAM-1的水平则没有升高。TNF-α和l -选择素在PTC患者原发肿瘤中的表达也明显高于良性甲状腺疾病。l -选择素和VCAM-1的表达与肿瘤侵袭性行为显著相关。PTC患者循环TNF-α水平与l -选择素水平显著正相关,TNF-α免疫反应性与VCAM-1表达显著相关。血清TNF-α被发现是PTC患者OS的重要预后指标。总的来说,这些结果表明TNF-α和粘附分子之间的相互作用可能在甲状腺癌变中起作用,了解这种复杂性可能为更好地治疗甲状腺癌提供潜在的治疗靶点。
{"title":"Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma","authors":"T. Kobawala, T. Trivedi, K. Gajjar, Darshita H. Patel, G. Patel, N. Ghosh","doi":"10.1155/2016/8143695","DOIUrl":"https://doi.org/10.1155/2016/8143695","url":null,"abstract":"Circulating levels of TNF-α and the adhesion molecules L-Selectin and VCAM-1 as well as their expression in the primary tumors of patients with benign thyroid diseases and papillary thyroid carcinoma (PTC) have been determined in this study. The serum levels of TNF-α, L-Selectin, and VCAM-1 were significantly higher in patients with both benign thyroid diseases and PTC as compared to the healthy individuals. However, the levels of only TNF-α and L-Selectin, and not VCAM-1, were significantly higher in patients with PTC in comparison to those observed in patients with benign thyroid diseases. Further the expression of TNF-α and L-Selectin was also significantly higher in the primary tumors of PTC patients, relative to the benign thyroid diseases. The expression of L-Selectin and VCAM-1 significantly correlated with aggressive tumor behavior. In PTC patients, the circulating TNF-α levels significantly positively correlated with the levels of L-Selectin, while TNF-α immunoreactivity was significantly associated with VCAM-1 expression. Serum TNF-α was found to be a significant prognosticator for OS in PTC patients. Overall the results signify that the interaction between TNF-α and the adhesion molecules may have a role in thyroid carcinogenesis and understanding this complexity may offer potential therapeutic targets for better management of thyroid cancer.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80090214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Corrigendum to "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer". “如何处理信号?”以ret基因型为导向选择治疗甲状腺髓样癌的激酶抑制剂的当前基础”。
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-06-28 DOI: 10.1155/2016/2168046
Hugo Prazeres, Joana Torres, Fernando Rodrigues, Joana P Couto, João Vinagre, Manuel Sobrinho-Simões, Paula Soares

[This corrects the article DOI: 10.4061/2011/678357.].

[这更正了文章DOI: 10.4061/2011/678357.]
{"title":"Corrigendum to \"How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer\".","authors":"Hugo Prazeres,&nbsp;Joana Torres,&nbsp;Fernando Rodrigues,&nbsp;Joana P Couto,&nbsp;João Vinagre,&nbsp;Manuel Sobrinho-Simões,&nbsp;Paula Soares","doi":"10.1155/2016/2168046","DOIUrl":"https://doi.org/10.1155/2016/2168046","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.4061/2011/678357.]. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/2168046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34683011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Population T4/TSH Set Point Data and T4/TSH Physiology. 人群T4/TSH设定点数据与T4/TSH生理的关系
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-03-31 DOI: 10.1155/2016/6351473
Stephen Paul Fitzgerald, Nigel Geoffrey Bean

Context. Population studies of the distribution of T4/TSH set points suggest a more complex inverse relationship between T4 and TSH than that suggested by physiological studies. The reasons for the similarities and differences between the curves describing these relationships are unresolved. Methods. We subjected the curve, derived from empiric data, describing the TSH suppression response to T4, and the more mathematically derived curve describing the T4 response to TSH, to the different possible models of population variation. The implied consequences of these in terms of generating a population distribution of T4/TSH equilibrium points (a "population curve") were generated and compared to the empiric population curve. The physiological responses to primary hypothyroidism and hyperthyroidism were incorporated into the analysis. Conclusions. Though the population curve shows a similarly inverse relationship, it is describing a different relationship than the curve describing the suppression of TSH by T4. The population curve is consistent with the physiological studies of the TSH response to T4 and implies a greater interindividual variation in the positive thyroid T4 response to TSH than in the central inhibitory TSH response to T4. The population curve in the dysthyroid states is consistent with known physiological responses to these states.

上下文。T4/TSH设定点分布的人群研究表明,T4和TSH之间的负相关关系比生理学研究表明的更为复杂。描述这些关系的曲线之间的相似和不同的原因尚未解决。方法。我们将从经验数据得出的描述T4对TSH抑制反应的曲线,以及更数学化的描述T4对TSH反应的曲线,应用于不同可能的种群变异模型。在生成T4/TSH平衡点(“人口曲线”)的人口分布方面,这些隐含的后果被生成并与经验人口曲线进行比较。对原发性甲状腺功能减退和甲状腺功能亢进的生理反应纳入分析。结论。尽管总体曲线显示出类似的反比关系,但它描述的关系与描述T4抑制TSH的曲线不同。人群曲线与TSH对T4反应的生理研究相一致,表明甲状腺T4对TSH的阳性反应比中枢抑制TSH对T4的反应有更大的个体差异。甲状腺功能障碍状态的人口曲线与已知的对这些状态的生理反应是一致的。
{"title":"The Relationship between Population T4/TSH Set Point Data and T4/TSH Physiology.","authors":"Stephen Paul Fitzgerald,&nbsp;Nigel Geoffrey Bean","doi":"10.1155/2016/6351473","DOIUrl":"https://doi.org/10.1155/2016/6351473","url":null,"abstract":"<p><p>Context. Population studies of the distribution of T4/TSH set points suggest a more complex inverse relationship between T4 and TSH than that suggested by physiological studies. The reasons for the similarities and differences between the curves describing these relationships are unresolved. Methods. We subjected the curve, derived from empiric data, describing the TSH suppression response to T4, and the more mathematically derived curve describing the T4 response to TSH, to the different possible models of population variation. The implied consequences of these in terms of generating a population distribution of T4/TSH equilibrium points (a \"population curve\") were generated and compared to the empiric population curve. The physiological responses to primary hypothyroidism and hyperthyroidism were incorporated into the analysis. Conclusions. Though the population curve shows a similarly inverse relationship, it is describing a different relationship than the curve describing the suppression of TSH by T4. The population curve is consistent with the physiological studies of the TSH response to T4 and implies a greater interindividual variation in the positive thyroid T4 response to TSH than in the central inhibitory TSH response to T4. The population curve in the dysthyroid states is consistent with known physiological responses to these states. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/6351473","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34439052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid. FRTL-5大鼠甲状腺细胞释放外泌体中隔离的甲状腺球蛋白:甲状腺中甲状腺球蛋白加工的可能新机制
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-06-09 DOI: 10.1155/2016/9276402
Pavel Vlasov, Sonia Q Doi, Donald F Sellitti

Exosomes are 30-100 nm, membrane-bound vesicles containing specific cellular proteins, mRNAs, and microRNAs that take part in intercellular communication between cells. A possible role for exosomes in thyroid function has not been fully explored. In the present study, FRTL-5 rat thyroid cells were grown to confluence and received medium containing either thyroid stimulating hormone (TSH), exogenous bovine thyroglobulin (bTg), or neither additive for 24 or 48 hours followed by collection of spent medium and ultracentrifugation to isolate small vesicles. Transmission electron microscopy and Western blotting for CD9 indicated the presence of exosomes. Western blotting of exosome extract using a monoclonal anti-Tg antibody revealed a Tg-positive band at ~330 kDa (the expected size of monomeric Tg) with a higher density in TSH-treated cells compared to that in untreated cells. These results are the first to show that normal thyroid cells in culture produce exosomes containing undegraded Tg.

外泌体是30-100 nm的膜结合囊泡,含有特定的细胞蛋白、mrna和microrna,参与细胞间的细胞间通讯。外泌体在甲状腺功能中的可能作用尚未得到充分探讨。本研究将FRTL-5大鼠甲状腺细胞培养至合流状态,并接受含有促甲状腺激素(TSH)、外源性牛甲状腺球蛋白(bTg)或不含任何添加剂的培养基,培养24或48小时,然后收集培养基并进行超离心分离小泡。CD9的透射电镜和Western blotting显示外泌体的存在。使用单克隆抗Tg抗体对外泌体提取物进行Western blotting,发现tsh处理的细胞中有一个约330 kDa(单体Tg的预期大小)的Tg阳性带,与未处理的细胞相比,tsh处理的细胞密度更高。这些结果首次表明,正常的甲状腺细胞在培养中产生含有未降解Tg的外泌体。
{"title":"FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid.","authors":"Pavel Vlasov,&nbsp;Sonia Q Doi,&nbsp;Donald F Sellitti","doi":"10.1155/2016/9276402","DOIUrl":"https://doi.org/10.1155/2016/9276402","url":null,"abstract":"<p><p>Exosomes are 30-100 nm, membrane-bound vesicles containing specific cellular proteins, mRNAs, and microRNAs that take part in intercellular communication between cells. A possible role for exosomes in thyroid function has not been fully explored. In the present study, FRTL-5 rat thyroid cells were grown to confluence and received medium containing either thyroid stimulating hormone (TSH), exogenous bovine thyroglobulin (bTg), or neither additive for 24 or 48 hours followed by collection of spent medium and ultracentrifugation to isolate small vesicles. Transmission electron microscopy and Western blotting for CD9 indicated the presence of exosomes. Western blotting of exosome extract using a monoclonal anti-Tg antibody revealed a Tg-positive band at ~330 kDa (the expected size of monomeric Tg) with a higher density in TSH-treated cells compared to that in untreated cells. These results are the first to show that normal thyroid cells in culture produce exosomes containing undegraded Tg. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/9276402","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34636847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer. 甲状腺癌患者甲状腺切除术后局部淋巴结复发的预测因素。
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-06-14 DOI: 10.1155/2016/4127278
Amirsina Sharifi, Abolfazl Shojaeifard, Ahmadreza Soroush, Mehdi Jafari, Ali Ghorbani Abdehgah, Hossein Mahmoudzade

Background. Regional lymph node recurrence (RLNR) is common in patients with thyroid cancer but clinicopathological predictors are unclear. We aimed to clarify these predictors and identify patients who would benefit from prophylactic lymph node dissection the most. Method. 343 patients with different types of thyroid cancer were analyzed retrospectively. All patients underwent total thyroidectomy between 2007 and 2013. Results. The median ± interquartile range of patients' age was 40 ± 25 years. 245 (71.4%) patients were female. Regarding the risk of regional lymph node recurrence, we found that male gender, age ≥45 years, non-PTC (i.e., medullary, follicular, and anaplastic types) histopathology, T3 (i.e., tumor size >4 cm in the greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension), stage IVa, and isolated cervical lymphadenopathy as initial manifestation (ICL) are significant risk factors. T3 (p < 0.001; odds ratio = 156.41, 95% CI [55.72-439.1]) and ICL (p < 0.001; odds ratio = 77.79, 95% CI [31.55-191.81]) were the strongest predictors of regional lymph node recurrence. Conclusion. We found easily achievable risk factors for RLNR in thyroid cancers patients. We suggested that patients with specific clinicopathological features like male gender, age ≥45 years, larger tumor size, and extrathyroidal extension be considered as prophylactic lymphadenectomy candidates.

背景。局部淋巴结复发(RLNR)在甲状腺癌患者中很常见,但临床病理预测因素尚不清楚。我们的目的是澄清这些预测因素,并确定从预防性淋巴结清扫中获益最多的患者。方法:对343例不同类型甲状腺癌患者的临床资料进行回顾性分析。所有患者均在2007年至2013年间接受了甲状腺全切除术。结果。患者年龄中位数±四分位数范围为40±25岁。女性245例(71.4%)。关于局部淋巴结复发的风险,我们发现男性、年龄≥45岁、非ptc(即髓样、滤泡型和间变性型)组织病理学、T3(即肿瘤尺寸> 4cm,最大局限于甲状腺或任何甲状腺外扩展最小的肿瘤)、IVa期和孤立性宫颈淋巴结病为初始表现(ICL)是重要的危险因素。T3 (p < 0.001);优势比= 156.41,95% CI[55.72 ~ 439.1])和ICL (p < 0.001;优势比= 77.79,95% CI[31.55 ~ 191.81])是区域淋巴结复发的最强预测因子。结论。我们发现了甲状腺癌患者RLNR容易达到的危险因素。我们建议有特定临床病理特征的患者,如男性、年龄≥45岁、肿瘤体积较大、甲状腺外扩张等,可考虑预防性淋巴结切除术。
{"title":"Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer.","authors":"Amirsina Sharifi,&nbsp;Abolfazl Shojaeifard,&nbsp;Ahmadreza Soroush,&nbsp;Mehdi Jafari,&nbsp;Ali Ghorbani Abdehgah,&nbsp;Hossein Mahmoudzade","doi":"10.1155/2016/4127278","DOIUrl":"https://doi.org/10.1155/2016/4127278","url":null,"abstract":"<p><p>Background. Regional lymph node recurrence (RLNR) is common in patients with thyroid cancer but clinicopathological predictors are unclear. We aimed to clarify these predictors and identify patients who would benefit from prophylactic lymph node dissection the most. Method. 343 patients with different types of thyroid cancer were analyzed retrospectively. All patients underwent total thyroidectomy between 2007 and 2013. Results. The median ± interquartile range of patients' age was 40 ± 25 years. 245 (71.4%) patients were female. Regarding the risk of regional lymph node recurrence, we found that male gender, age ≥45 years, non-PTC (i.e., medullary, follicular, and anaplastic types) histopathology, T3 (i.e., tumor size >4 cm in the greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension), stage IVa, and isolated cervical lymphadenopathy as initial manifestation (ICL) are significant risk factors. T3 (p < 0.001; odds ratio = 156.41, 95% CI [55.72-439.1]) and ICL (p < 0.001; odds ratio = 77.79, 95% CI [31.55-191.81]) were the strongest predictors of regional lymph node recurrence. Conclusion. We found easily achievable risk factors for RLNR in thyroid cancers patients. We suggested that patients with specific clinicopathological features like male gender, age ≥45 years, larger tumor size, and extrathyroidal extension be considered as prophylactic lymphadenectomy candidates. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/4127278","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34724094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Change in Practice over Four Decades in the Management of Graves' Disease in Scotland. 苏格兰四十年来Graves病管理实践的变化
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-05-30 DOI: 10.1155/2016/9697849
D M Smith, S Dutta, F Ahmed, M A Thaha
There is continuing debate on the optimal treatment for Grave's thyrotoxicosis with a resultant variation in clinical practice. The present study aimed to ascertain changes in practice in the treatment of Grave's thyrotoxicosis in Tayside, Scotland, over the past four decades. Methods. The “Scottish automated follow-up register” (SAFUR) was queried to identify all patients treated for Grave's thyrotoxicosis from 1968 to 2007 inclusive. Patients were divided into 4 groups (Groups A to D) according to the decades. Demographic profile, treatment modalities, radioactive iodine (RAI) dose, and recurrence rates were studied and outcomes were compared by χ 2 test and ANOVA using SPSS v15.0. A p value of < 0.05 was considered significant. Results. Altogether, 3737 patients were diagnosed with Grave's thyrotoxicosis over the 4 decades. Use of RAI has increased from 43.1% in Group A to 68% in Group D (p < 0.001). The dose of RAI has increased (p < 0.001) and there has been a reduction in recurrence rate with higher dose of RAI. Surgical intervention rates decreased from 55.3% to 12.3% (p < 0.001) over time. Conclusions. Analysis of a large dataset of patients with Grave's thyrotoxicosis suggests increasing use of RAI as the preferred first line of treatment. Furthermore, using a single higher dose of RAI and adoption of total thyroidectomy have decreased recurrence rates.
关于格雷夫氏甲状腺毒症的最佳治疗方法,在临床实践中一直存在争议。本研究旨在确定过去四十年来苏格兰泰赛德格雷夫甲状腺毒症治疗实践的变化。方法。对“苏格兰自动随访登记”(SAFUR)进行查询,以确定1968年至2007年期间接受格雷夫甲状腺毒症治疗的所有患者。患者按年龄分为A ~ D组。研究患者的人口学概况、治疗方式、放射性碘(RAI)剂量和复发率,并采用χ(2)检验和方差分析,采用SPSS v15.0进行比较。p值< 0.05为显著性。结果。在过去的40年里,总共有3737名患者被诊断为格雷夫氏甲状腺毒症。RAI的使用率从A组的43.1%上升到D组的68% (p < 0.001)。RAI剂量增加(p < 0.001), RAI剂量越高,复发率越低。随着时间的推移,手术干预率从55.3%下降到12.3% (p < 0.001)。结论。对格雷夫氏甲状腺毒症患者的大型数据集的分析表明,RAI作为首选的一线治疗方法的使用越来越多。此外,使用单一高剂量的RAI和采用甲状腺全切除术可降低复发率。
{"title":"Change in Practice over Four Decades in the Management of Graves' Disease in Scotland.","authors":"D M Smith,&nbsp;S Dutta,&nbsp;F Ahmed,&nbsp;M A Thaha","doi":"10.1155/2016/9697849","DOIUrl":"https://doi.org/10.1155/2016/9697849","url":null,"abstract":"There is continuing debate on the optimal treatment for Grave's thyrotoxicosis with a resultant variation in clinical practice. The present study aimed to ascertain changes in practice in the treatment of Grave's thyrotoxicosis in Tayside, Scotland, over the past four decades. Methods. The “Scottish automated follow-up register” (SAFUR) was queried to identify all patients treated for Grave's thyrotoxicosis from 1968 to 2007 inclusive. Patients were divided into 4 groups (Groups A to D) according to the decades. Demographic profile, treatment modalities, radioactive iodine (RAI) dose, and recurrence rates were studied and outcomes were compared by χ 2 test and ANOVA using SPSS v15.0. A p value of < 0.05 was considered significant. Results. Altogether, 3737 patients were diagnosed with Grave's thyrotoxicosis over the 4 decades. Use of RAI has increased from 43.1% in Group A to 68% in Group D (p < 0.001). The dose of RAI has increased (p < 0.001) and there has been a reduction in recurrence rate with higher dose of RAI. Surgical intervention rates decreased from 55.3% to 12.3% (p < 0.001) over time. Conclusions. Analysis of a large dataset of patients with Grave's thyrotoxicosis suggests increasing use of RAI as the preferred first line of treatment. Furthermore, using a single higher dose of RAI and adoption of total thyroidectomy have decreased recurrence rates.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/9697849","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34650745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. 胰腺癌甲状腺功能减退:外源性甲状腺激素在肿瘤侵袭中的作用——初步观察。
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-03-31 DOI: 10.1155/2016/2454989
Konrad Sarosiek, Ankit V Gandhi, Shivam Saxena, Christopher Y Kang, Galina I Chipitsyna, Charles J Yeo, Hwyda A Arafat

According to the epidemiological studies, about 4.4% of American general elderly population has a pronounced hypothyroidism and relies on thyroid hormone supplements daily. The prevalence of hypothyroidism in our patients with pancreatic cancer was much higher, 14.1%. A retrospective analysis was performed on patients who underwent pancreaticoduodenectomy (Whipple procedure) or distal pancreatectomy and splenectomy (DPS) at Thomas Jefferson University Hospital, Philadelphia, from 2005 to 2012. The diagnosis of hypothyroidism was correlated with clinicopathologic parameters including tumor stage, grade, and survival. To further understand how thyroid hormone affects pancreatic cancer behavior, functional studies including wound-induced cell migration, proliferation, and invasion were performed on pancreatic cancer cell lines, MiaPaCa-2 and AsPC-1. We found that hypothyroid patients taking exogenous thyroid hormone were more than three times likely to have perineural invasion, and about twice as likely to have higher T stage, nodal spread, and overall poorer prognostic stage (P < 0.05). Pancreatic cancer cell line studies demonstrated that exogenous thyroid hormone treatment increased cell proliferation, migration, and invasion (P < 0.05). We conclude that exogenous thyroid hormone may contribute to the progression of pancreatic cancer.

根据流行病学研究,约4.4%的美国普通老年人患有明显的甲状腺功能减退症,每天需要补充甲状腺激素。我们的胰腺癌患者甲状腺功能减退的患病率要高得多,为14.1%。回顾性分析了2005年至2012年在费城托马斯杰斐逊大学医院接受胰十二指肠切除术(Whipple手术)或远端胰切除术和脾切除术(DPS)的患者。甲状腺功能减退的诊断与临床病理参数相关,包括肿瘤分期、分级和生存。为了进一步了解甲状腺激素如何影响胰腺癌行为,我们对胰腺癌细胞系MiaPaCa-2和AsPC-1进行了功能研究,包括伤口诱导的细胞迁移、增殖和侵袭。我们发现,服用外源性甲状腺激素的甲状腺功能减退患者发生神经周围侵犯的可能性是服用外源性甲状腺激素的患者的3倍以上,发生高T期、淋巴结转移和总体预后不良期的可能性是服用外源性甲状腺激素的患者的2倍左右(P < 0.05)。胰腺癌细胞系研究表明,外源性甲状腺激素治疗增加了细胞的增殖、迁移和侵袭(P < 0.05)。我们得出结论,外源性甲状腺激素可能有助于胰腺癌的进展。
{"title":"Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations.","authors":"Konrad Sarosiek,&nbsp;Ankit V Gandhi,&nbsp;Shivam Saxena,&nbsp;Christopher Y Kang,&nbsp;Galina I Chipitsyna,&nbsp;Charles J Yeo,&nbsp;Hwyda A Arafat","doi":"10.1155/2016/2454989","DOIUrl":"https://doi.org/10.1155/2016/2454989","url":null,"abstract":"<p><p>According to the epidemiological studies, about 4.4% of American general elderly population has a pronounced hypothyroidism and relies on thyroid hormone supplements daily. The prevalence of hypothyroidism in our patients with pancreatic cancer was much higher, 14.1%. A retrospective analysis was performed on patients who underwent pancreaticoduodenectomy (Whipple procedure) or distal pancreatectomy and splenectomy (DPS) at Thomas Jefferson University Hospital, Philadelphia, from 2005 to 2012. The diagnosis of hypothyroidism was correlated with clinicopathologic parameters including tumor stage, grade, and survival. To further understand how thyroid hormone affects pancreatic cancer behavior, functional studies including wound-induced cell migration, proliferation, and invasion were performed on pancreatic cancer cell lines, MiaPaCa-2 and AsPC-1. We found that hypothyroid patients taking exogenous thyroid hormone were more than three times likely to have perineural invasion, and about twice as likely to have higher T stage, nodal spread, and overall poorer prognostic stage (P < 0.05). Pancreatic cancer cell line studies demonstrated that exogenous thyroid hormone treatment increased cell proliferation, migration, and invasion (P < 0.05). We conclude that exogenous thyroid hormone may contribute to the progression of pancreatic cancer. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/2454989","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34439051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Association between Tumor Size and Bilateral Involvement in Papillary Thyroid Carcinoma. 甲状腺乳头状癌肿瘤大小与双侧受累的关系。
IF 2.1 Q2 Medicine Pub Date : 2016-01-01 Epub Date: 2016-04-24 DOI: 10.1155/2016/8470252
Suna Erkilic, Fatih Celenk, Zehra Bozdag

Background. Tumor multifocality and bilaterality of papillary thyroid carcinoma (PTC) are important factors when selecting the most appropriate surgical procedure. The aim of this study was to assess the bilaterality rate in PTC and the relationship between the tumor size and bilaterality. Materials and Methods. Thyroidectomy specimens with a diagnosis of PTC were retrospectively reviewed in the Pathology Department of a tertiary care medical center. Specimens were divided into three groups according to the size of the primary and contralateral tumor foci. Tumors less than or equal to 1 cm in each lobe were included in group 1. Group 2 consisted of tumors greater than 1 cm in one lobe and less than 1 cm in the other lobe. Tumors greater than 1 cm in each lobe were included in group 3. Results. We identified 868 total thyroidectomy specimens with a diagnosis of PTC between 2001 and 2011. Of these cases, both thyroid lobes were involved in 262 cases (32%). There were 109 (42%), 121 (46%), and 32 cases (12%) in group 1, group 2, and group 3, respectively. Conclusion. Bilaterality is frequent in PTC and is not related to tumor size. Accordingly, the high frequency of bilateral disease in PTC should be kept in mind when determining the extent of the surgical procedure.

背景。甲状腺乳头状癌(PTC)的多灶性和双侧性是选择最合适的手术方式的重要因素。本研究的目的是评估PTC的双侧发生率以及肿瘤大小与双侧的关系。材料与方法。我们在一家三级医疗中心的病理科回顾了诊断为PTC的甲状腺切除术标本。根据原发和对侧肿瘤病灶大小,将标本分为三组。每叶小于或等于1cm的肿瘤为1组。第二组为一侧肺叶肿瘤大于1cm,另一侧肺叶肿瘤小于1cm。每叶大于1cm的肿瘤为第三组。结果。我们在2001年至2011年间鉴定了868例诊断为PTC的全甲状腺切除术标本。其中双侧甲状腺叶累及262例(32%)。1组109例(42%),2组121例(46%),3组32例(12%)。结论。双侧病变在PTC中很常见,与肿瘤大小无关。因此,在确定手术范围时,应牢记PTC双侧疾病的高频率。
{"title":"Association between Tumor Size and Bilateral Involvement in Papillary Thyroid Carcinoma.","authors":"Suna Erkilic,&nbsp;Fatih Celenk,&nbsp;Zehra Bozdag","doi":"10.1155/2016/8470252","DOIUrl":"https://doi.org/10.1155/2016/8470252","url":null,"abstract":"<p><p>Background. Tumor multifocality and bilaterality of papillary thyroid carcinoma (PTC) are important factors when selecting the most appropriate surgical procedure. The aim of this study was to assess the bilaterality rate in PTC and the relationship between the tumor size and bilaterality. Materials and Methods. Thyroidectomy specimens with a diagnosis of PTC were retrospectively reviewed in the Pathology Department of a tertiary care medical center. Specimens were divided into three groups according to the size of the primary and contralateral tumor foci. Tumors less than or equal to 1 cm in each lobe were included in group 1. Group 2 consisted of tumors greater than 1 cm in one lobe and less than 1 cm in the other lobe. Tumors greater than 1 cm in each lobe were included in group 3. Results. We identified 868 total thyroidectomy specimens with a diagnosis of PTC between 2001 and 2011. Of these cases, both thyroid lobes were involved in 262 cases (32%). There were 109 (42%), 121 (46%), and 32 cases (12%) in group 1, group 2, and group 3, respectively. Conclusion. Bilaterality is frequent in PTC and is not related to tumor size. Accordingly, the high frequency of bilateral disease in PTC should be kept in mind when determining the extent of the surgical procedure. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/8470252","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34572373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective 艾滋病毒感染和获得性免疫缺陷综合征患者甲状腺功能障碍的患病率和预测因素:印度视角
IF 2.1 Q2 Medicine Pub Date : 2015-12-22 DOI: 10.1155/2015/517173
N. Sharma, Lokesh Sharma, D. Dutta, A. K. Gadpayle, A. Anand, K. Gaurav, S. Mukherjee, R. Bansal
Background. Predictors of thyroid dysfunction in HIV are not well determined. This study aimed to determine the prevalence and predictors of thyroid dysfunction in HIV infected Indians. Methods. Consecutive HIV patients, 18–70 years of age, without any severe comorbid state, having at least 1-year follow-up at the antiretroviral therapy clinic, underwent clinical assessment and hormone assays. Results. From initially screened 527 patients, 359 patients (61.44 ± 39.42 months' disease duration), having good immune function [CD4 count >200 cell/mm3: 90.25%; highly active antiretroviral therapy (HAART): 88.58%], were analyzed. Subclinical hypothyroidism (ScH) was the commonest thyroid dysfunction (14.76%) followed by sick euthyroid syndrome (SES) (5.29%) and isolated low TSH (3.1%). Anti-TPO antibody (TPOAb) was positive in 3.90%. Baseline CD4 count had inverse correlation with TPOAb after adjusting for age and body mass index. Stepwise linear regression revealed baseline CD4 count, TPOAb, and tuberculosis to be best predictors of ScH after adjusting for age, weight, duration of HIV, and history of opportunistic fungal and viral infections. Conclusion. Burden of thyroid dysfunction in chronic HIV infection with stable immune function is lower compared to pre-HAART era. Thyroid dysfunction is primarily of nonautoimmune origin, predominantly ScH. Severe immunodeficiency at disease onset, TPOAb positivity, and tuberculosis were best predictors of ScH.
背景。HIV患者甲状腺功能障碍的预测因素尚未确定。本研究旨在确定印度HIV感染者甲状腺功能障碍的患病率和预测因素。方法。连续的HIV患者,年龄18-70岁,无任何严重合并症,在抗逆转录病毒治疗诊所随访至少1年,接受临床评估和激素检测。结果。从最初筛选的527例患者中,359例患者(病程61.44±39.42个月)免疫功能良好[CD4计数>200细胞/mm3: 90.25%;高活性抗逆转录病毒治疗(HAART): 88.58%]。亚临床甲状腺功能减退(ScH)是最常见的甲状腺功能障碍(14.76%),其次是病态甲状腺功能正常综合征(SES)(5.29%)和孤立性低TSH(3.1%)。抗tpo抗体(TPOAb)阳性率为3.90%。在调整年龄和体重指数后,基线CD4计数与TPOAb呈负相关。逐步线性回归显示,在调整年龄、体重、HIV持续时间以及机会性真菌和病毒感染史后,基线CD4计数、TPOAb和结核病是ScH的最佳预测因子。结论。与haart前相比,免疫功能稳定的慢性HIV感染者甲状腺功能障碍负担较低。甲状腺功能障碍主要是非自身免疫性的,主要是ScH。发病时严重免疫缺陷、TPOAb阳性和结核病是ScH的最佳预测因子。
{"title":"Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective","authors":"N. Sharma, Lokesh Sharma, D. Dutta, A. K. Gadpayle, A. Anand, K. Gaurav, S. Mukherjee, R. Bansal","doi":"10.1155/2015/517173","DOIUrl":"https://doi.org/10.1155/2015/517173","url":null,"abstract":"Background. Predictors of thyroid dysfunction in HIV are not well determined. This study aimed to determine the prevalence and predictors of thyroid dysfunction in HIV infected Indians. Methods. Consecutive HIV patients, 18–70 years of age, without any severe comorbid state, having at least 1-year follow-up at the antiretroviral therapy clinic, underwent clinical assessment and hormone assays. Results. From initially screened 527 patients, 359 patients (61.44 ± 39.42 months' disease duration), having good immune function [CD4 count >200 cell/mm3: 90.25%; highly active antiretroviral therapy (HAART): 88.58%], were analyzed. Subclinical hypothyroidism (ScH) was the commonest thyroid dysfunction (14.76%) followed by sick euthyroid syndrome (SES) (5.29%) and isolated low TSH (3.1%). Anti-TPO antibody (TPOAb) was positive in 3.90%. Baseline CD4 count had inverse correlation with TPOAb after adjusting for age and body mass index. Stepwise linear regression revealed baseline CD4 count, TPOAb, and tuberculosis to be best predictors of ScH after adjusting for age, weight, duration of HIV, and history of opportunistic fungal and viral infections. Conclusion. Burden of thyroid dysfunction in chronic HIV infection with stable immune function is lower compared to pre-HAART era. Thyroid dysfunction is primarily of nonautoimmune origin, predominantly ScH. Severe immunodeficiency at disease onset, TPOAb positivity, and tuberculosis were best predictors of ScH.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2015-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79100781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy 有和没有甲状腺疾病的受试者脑脊液中的甲状腺自身抗体:对桥本脑病的影响
IF 2.1 Q2 Medicine Pub Date : 2015-12-21 DOI: 10.1155/2015/819072
I. Ilias, V. Karagiorga, G. Paraskevas, A. Bougea, Maria Bourbouli, A. Pappa, S. Nikopoulou, E. Kapaki
Introduction. Plasma antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-Tg) are widely used in the diagnosis of autoimmune thyroiditis. No research has compared anti-TPO and anti-Tg both in plasma and cerebrospinal fluid (CSF) of healthy individuals vis-à-vis patients with thyroid disease. Methods. We measured anti-TPO and anti-Tg antibodies in plasma and CSF in nine subjects (mean age ± SD: 73 ± 6 years) with hypothyroidism and nine subjects (mean age ± SD: 73 ± 8 years) without thyroid disease. Results. The concentration of anti-TPO autoantibodies in CSF was very low compared to plasma in both subjects with thyroid and without thyroid disease (P = 0.007). CSF anti-Tg autoantibodies titers were very low compared to the plasma in subjects with thyroid disease (P = 0.004), whereas, in subjects without thyroid disease, this difference did not reach statistical significance (P = 0.063). Conclusions. Thyroid autoantibodies levels were low in plasma and CSF; we did not observe any transfer of thyroid autoantibodies from the peripheral blood to the CSF. Therefore, regarding Hashimoto's encephalopathy, where elevated antithyroid autoantibodies are often measured in blood, it is more likely that thyroiditis and encephalopathy represent nonspecific, but distinct, events of an aggressive immune system.
介绍。血浆抗甲状腺过氧化物酶(anti-TPO)和抗甲状腺球蛋白抗体(anti-Tg)被广泛用于自身免疫性甲状腺炎的诊断。目前还没有研究将健康人血浆和脑脊液中的抗tpo和抗tg与-à-vis甲状腺疾病患者进行比较。方法。我们检测了9例甲状腺功能减退患者(平均年龄±SD: 73±6岁)和9例无甲状腺疾病患者(平均年龄±SD: 73±8岁)血浆和脑脊液中抗tpo和抗tg抗体。结果。与有甲状腺和无甲状腺疾病的受试者相比,脑脊液中抗tpo自身抗体的浓度都很低(P = 0.007)。甲状腺疾病患者脑脊液抗tg自身抗体滴度与血浆相比非常低(P = 0.004),而非甲状腺疾病患者脑脊液抗tg自身抗体滴度与血浆相比差异无统计学意义(P = 0.063)。结论。血浆和脑脊液中甲状腺自身抗体水平低;我们没有观察到甲状腺自身抗体从外周血到脑脊液的任何转移。因此,对于桥本脑病(血液中经常检测到抗甲状腺自身抗体升高),甲状腺炎和脑病更有可能是非特异性的,但不同的,侵袭性免疫系统的事件。
{"title":"Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy","authors":"I. Ilias, V. Karagiorga, G. Paraskevas, A. Bougea, Maria Bourbouli, A. Pappa, S. Nikopoulou, E. Kapaki","doi":"10.1155/2015/819072","DOIUrl":"https://doi.org/10.1155/2015/819072","url":null,"abstract":"Introduction. Plasma antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-Tg) are widely used in the diagnosis of autoimmune thyroiditis. No research has compared anti-TPO and anti-Tg both in plasma and cerebrospinal fluid (CSF) of healthy individuals vis-à-vis patients with thyroid disease. Methods. We measured anti-TPO and anti-Tg antibodies in plasma and CSF in nine subjects (mean age ± SD: 73 ± 6 years) with hypothyroidism and nine subjects (mean age ± SD: 73 ± 8 years) without thyroid disease. Results. The concentration of anti-TPO autoantibodies in CSF was very low compared to plasma in both subjects with thyroid and without thyroid disease (P = 0.007). CSF anti-Tg autoantibodies titers were very low compared to the plasma in subjects with thyroid disease (P = 0.004), whereas, in subjects without thyroid disease, this difference did not reach statistical significance (P = 0.063). Conclusions. Thyroid autoantibodies levels were low in plasma and CSF; we did not observe any transfer of thyroid autoantibodies from the peripheral blood to the CSF. Therefore, regarding Hashimoto's encephalopathy, where elevated antithyroid autoantibodies are often measured in blood, it is more likely that thyroiditis and encephalopathy represent nonspecific, but distinct, events of an aggressive immune system.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2015-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88893319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Journal of Thyroid Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1